Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Guideline for phase I study on new anticancer agents].

M Shimoyama1

  • 1Nagoya National Hospital, 4-1-1 Sannomaru, Naka-ku, Nagoya 460-0001, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prevalence of mental health problems in adults with intellectual disabilities in Japan, associated factors and mental health service use.

Journal of intellectual disability research : JIDR·2018
Same author

The Differences between Lymphoma and Leukemia Type of Adult T-cell Leukemia.

Leukemia & lymphoma·2016
Same author

Retrospective evaluation of the effect of carotid artery stenosis on cerebral oxygen saturation during off-pump coronary artery bypasses grafting in adult patients.

BMC anesthesiology·2015
Same author

Perfusion index derived from a pulse oximeter can predict the incidence of hypotension during spinal anaesthesia for Caesarean delivery.

British journal of anaesthesia·2013
Same author

Gene Ontology annotations and resources.

Nucleic acids research·2012
Same author

Goal-directed fluid therapy in patients undergoing colorectal surgery.

British journal of anaesthesia·2012

New anticancer agents require careful evaluation in phase I clinical trials. This guideline addresses critical scientific, medical, statistical, and ethical issues, focusing on clinical safety data management for novel cancer therapies.

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Research

Context:

  • Standard cancer therapies are insufficient for over 50% of patients, necessitating novel therapeutic strategies.
  • Phase I clinical trials are crucial for evaluating the safety and efficacy of new anticancer agents.
  • Existing guidelines require updates to address the complexities of early-phase cancer drug development.

Purpose:

  • To provide a comprehensive guideline for conducting phase I studies of new anticancer agents.
  • To outline key considerations including scientific, medical, statistical, and ethical aspects.
  • To emphasize the critical role of clinical safety data management in phase I trials.

Summary:

  • This paper presents essential components of a guideline for phase I studies on new anticancer agents.

Related Experiment Videos

  • It addresses critical issues in evaluating novel cancer drugs from multiple perspectives.
  • Focus is placed on robust clinical safety data management, vital for patient protection.

    • Impact:

    • Aims to improve the design and execution of phase I cancer clinical trials.
    • Facilitates the rigorous evaluation of promising new anticancer therapies.
    • Contributes to the development of safer and more effective cancer treatments.